The minimum dose of dexmedetomidine required for cessation of postspinal anesthesia shivering: A prospective observational study

BACKGROUND AND AIMS: Shivering is a common postanesthesia adverse event with multiple etiologies. Dexmedetomidine, a centrally acting alpha-2 adrenergic agonist, is known to reduce the shivering threshold. However, the minimum dose at which dexmedetomidine causes cessation of shivering is unknown. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Kundra, Tanveer Singh, Kaur, Parminder
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5791263/
https://www.ncbi.nlm.nih.gov/pubmed/29416242
http://dx.doi.org/10.4103/joacp.JOACP_115_16

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5791263/
https://www.ncbi.nlm.nih.gov/pubmed/29416242
http://dx.doi.org/10.4103/joacp.JOACP_115_16

Ejemplares similares